Helminth defence molecules-immunomodulators designed by parasites!

Frontiers in Microbiology

Volumn 4, Issue OCT, 2013, Pages

  Robinson, Mark W ^a   Donnelly, Sheila ^b   Dalton, John P ^a,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antimicrobial peptide; Fasciola; Helminth; Helminth defence molecule; Immunomodulator; Parasite; Schistosoma; Trematodes

Indexed keywords

ANTIPARASITIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYSTEINE PROTEINASE; GAMMA INTERFERON; HELMINTH DEFENCE MOLECULE; IMMUNOMODULATING AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEOME; SECRETORY PROTEIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; FASCIOLA HEPATICA; HELMINTH; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; LEISHMANIA MAJOR; LIPID RAFT; MACROPHAGE; NONHUMAN; PHYLOGENY;

FASCIOLA; SCHISTOSOMA; TREMATODA; VERMES;

EID: 84885397045     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00296     Document Type: Article

References (30)

1. Brender, J. R., McHenry, A. J., and Ramamoorthy, A. (2012). Does cholesterol play a role in the bacterial selectivity of antimicrobial peptides? Front. Immunol. 3:195. doi: 10.3389/fimmu.2012.00195
2. Brown, K. L., Poon, G. F., Birkenhead, D., Pena, O. M., Falsafi, R., Dahlgren, C., et al. (2011). Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J. Immunol. 186, 5497-5505. doi: 10.4049/jimmunol.1002508
3. Carryn, S., Schaefer, D. A., Imboden, M., Homan, E. J., Bremel, R. D., and Riggs, M. W. (2012). Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoiteinfectivity by parasiticidal and non-parasiticidal mechanisms. J. Parasitol. 98, 199-204. doi: 10.1645/GE-2822.1
4. Ciornei, C. D., Sigurdardottir, T., Schmidtchen, A., and Bodelsson, M. (2005). Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob. Agents Chemother. 49, 2845-2850. doi: 10.1128/AAC.49.7.2845-2850.2005
5. Devocelle, M. (2012). Targeted antimicrobial peptides. Front. Immunol. 3:309. doi: 10.3389/fimmu.2012.00309
6. Donnelly, S., O'Neill, S. M., Sekiya, M., Mulcahy, G., and Dalton, J. P. (2005). Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect. Immun. 73, 166-173. doi: 10.1128/IAI.73.1.166-173.2005
7. Donnelly, S., O'Neill, S. M., Stack, C. M., Robinson, M. W., Turnbull, L., Whitchurch, C., et al. (2010). Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J. Biol. Chem. 285, 3383-3392. doi: 10.1074/jbc.m109.060368
8. Donnelly, S., Robinson, M. W., Dalton, J. P., and To, J. (2011). Immune modulating agents and uses therefor. PCT/AU2011/001402.
9. Donnelly, S., Stack, C. M., O'Neill, S. M., Sayed, A. A., Williams, D. L., and Dalton, J. P. (2008). Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J. 22, 4022-4032. doi: 10.1096/fj.08-106278
10. Easton, D. M., Nijnik, A., Mayer, M. L., and Hancock, R. E. (2009). Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 27, 582-590. doi: 10.1016/j.tibtech.2009.07.004
11. Haines, L. R., Thomas, J. M., Jackson, A. M., Eyford, B. A., Razavi, M., Watson, C. N., et al. (2009). Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. PLoS Negl. Trop. Dis. 3:e373. doi: 10.1371/journal.pntd.0000373
12. Hancock, R. E., and Chapple, D. S. (1999). Peptide antibiotics. Antimicrob. Agents Chemother. 43, 1317-1323.
13. Harnett, W., and Harnett, M. M. (2010). Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat. Rev. Immunol. 10, 278-284. doi: 10.1038/nri2730
14. Held, T. K., Weihua, X., Yuan, L., Kalvakolanu, D. V., and Cross, A. S. (1999). Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect. Immun. 67, 206-212.
15. Hotez, P. J., Brindley, P. J., Bethony, J. M., King, C. H., Pearce, E. J., and Jacobson, J. (2008). Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118, 1311-1321. doi: 10.1172/JCI34261
16. Jefferies, J. R., Campbell, A. M., van Rossum, A. J., Barrett, J., and Brophy, P. M. (2001). Proteomic analysis of Fasciola hepatica excretory-secretory products. Proteomics 1, 1128-1132.
17. Lowther, J., Robinson, M. W., Donnelly, S. M., Xu, W., Stack, C. M., Matthews, J. M., et al. (2009). The importance of pH in regulating the function of Fasciola hepatica cathepsin L1 cysteine protease. PLoS Negl. Trop. Dis. 3:e369. doi: 10.1371/journal.pntd.0000369
18. Lynn, M. A., Kindrachuk, J., Marr, A. K., Jenssen, H., Pante, N., Elliott, M. R., et al. (2011). Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival. PLoS Negl. Trop. Dis. 5:e1141. doi: 10.1371/journal.pntd.0001141
19. McGonigle, L., Mousley, A., Marks, N. J., Brennan, G. P., Dalton, J. P., Spithill, T. W., et al. (2008). The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference reduces gut penetration. Int. J. Parasitol. 38, 149-155. doi: 10.1016/j.ijpara.2007.10.007
20. Nishio, N., Ito, S., Suzuki, H., and Isobe, K. (2009). Antibodies to wounded tissue enhance cutaneous wound healing. Immunology 128, 369-380. doi: 10.1111/j.1365-2567.2009.03119.x
21. Oren, Z., and Shai, Y. (1998). Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47, 451-463.
22. Robinson, M. W., Alvarado, R., To, J., Hutchinson, A. T., Dowdell, S. N., Lund, M., et al. (2012). A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. FASEB J. 26, 4614-4627. doi: 10.1096/fj.12-213876
23. Robinson, M. W., Dalton, J. P., and Donnelly, S. (2008a). Helminth pathogen cathepsin proteases: it's a family affair. Trends Biochem. Sci. 33, 601-608. doi: 10.1016/j.tibs.2008.09.001
24. Robinson, M. W., Tort, J. F., Wong, E., Donnelly, S. M., Lowther, J., Xu, W., et al. (2008b). Proteomics and phylogenetic analysis of the cathepsin L protease family of the helminth pathogen, Fasciola hepatica: expansion of a repertoire of virulence-associated factors. Mol. Cell. Proteomics 7, 1111-1123. doi: 10.1074/mcp.M700560-MCP200
25. Robinson, M. W., Dalton, J. P., O'Brien, B. A., and Donnelly, S. (2013). Fasciola hepatica: the therapeutic potential of a worm secretome. Int. J. Parasitol. 43, 283-291.
26. Robinson, M. W., Donnelly, S., Hutchinson, A. T., To, J., Taylor, N. L., Norton, R. S., et al. (2011). A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog. 7:e1002042. doi: 10.1371/journal.ppat.1002042
27. Robinson, M. W., Menon, R., Donnelly, S. M., Dalton, J. P., and Ranganathan, S. (2009). An integrated transcriptomic and proteomic analysis of the secretome of the helminth pathogen, Fasciola hepatica: proteins associated with invasion and infection of the mammalian host. Mol. Cell. Proteomics 8, 1891-1907. doi: 10.1074/mcp.M900045-MCP200
28. Schroder, K., Sweet, M. J., and Hume, D. A. (2006). Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211, 511-524. doi: 10.1016/j.imbio.2006.05.007
29. Sood, R., and Kinnunen, P. K. (2008). Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L. Biochim. Biophys. Acta 1778, 1460-1466. doi: 10.1016/j.bbamem.2008.02.014
30. Thivierge, K., Cotton, S., Schaefer, D. A., Riggs, M. W., To, J., Lund, M. E., et al. (2013). Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation. PLoS Negl. Trop. Dis. 7:e2307. doi: 10.1371/journal.pntd.0002307